Chlorthalidone pharmacodynamics in beagle dogs

Area of Science:

• Pharmacology
• Pharmacokinetics
• Drug Formulation

Background:

• Chlorthalidone's diuretic effect requires understanding its absorption and distribution.
• Erythrocyte partitioning and plasma concentration influence chlorthalidone's efficacy.

Purpose of the Study:

• To optimize oral dosage formulation of chlorthalidone.
• To investigate chlorthalidone's pharmacokinetic and pharmacodynamic properties.

Main Methods:

• Pharmacodynamic and pharmacokinetic studies in beagle dogs.
• In vitro and in vivo partitioning assessments.
• Development of a pharmacokinetic model.
• Comparison of novel amorphous tablet with existing formulations.

Main Results:

• Chlorthalidone partitioning into erythrocytes is non-instantaneous (18 min half-life).
• Diuretic effect correlates with plasma drug concentration.
• Rapidly dissolving amorphous chlorthalidone tablets are bioequivalent to oral solutions.
• Crystalline chlorthalidone formulations show incomplete absorption.

Conclusions:

• Oral absorption rate significantly impacts chlorthalidone's diuretic efficacy.
• A novel, rapidly dissolving, amorphous chlorthalidone tablet optimizes plasma levels for diuretic response.
• This formulation enhances therapeutic outcomes compared to crystalline preparations.